viernes, 31 de julio de 2015

Centers for Disease Control and Prevention (CDC) Health Matters for Women[TM] E-Newsletter Update

Centers for Disease Control and Prevention (CDC) Health Matters for Women[TM] E-Newsletter Update



Health Matters for Women newsletter from the CDC - US Department of Health and Human Services - Centers for Disease Control and Prevention

Federal Agency News

National, State and Local News

Global


CDC Podcasts
Listen to the latest podcasts on women’s health.
CDC E-Cards
Send women’s health e-cards.


New from CDC

Prevalence of Disability and Disability Type Among Adults — United States, 2013
Women reported a higher prevalence of any disability (24.4%) than did men (19.8%), and also reported higher prevalences of each disability type.
Additional Guidance Online for Providers Regarding 9-Valent HPV Vaccine Use Among Persons Who Previously Received HPV Vaccination
Additional information provides guidance on issues not addressed in the March report, including questions about use of 9-valent HPV vaccine among persons who previously received bivalent or quadrivalent HPV vaccine.
Girlfriends’ Health
Friends can offer great support, work out with you, and call your attention to matters you may be ignoring. Get tips to help you and your friends stay healthy and safe. August 1 is National Girlfriends Day. Encourage your friends to be healthy!
Leading Cause of Death Tables, Females, 2013
Seven tables provide information on leading causes of death by age groups and race/ethnicity.
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2014
From 2013 to 2014, vaccination coverage among adolescents aged 13–17 years increased for all vaccines routinely recommended for adolescents. In six of the seven jurisdictions with increases in ≥1- or ≥3-dose HPV coverage among females, combinations of strategies were important.
Americans with Disabilities Act (ADA) 25th Anniversary
The landmark Americans with Disabilities Act is a civil rights law that strengthens the inclusion of people with disabilities at work, school, or other community settings. Learn what CDC is doing, including work with women with disabilities.
Bring Your Brave Campaign
The Bring Your Brave campaign provides information about breast cancer to women younger than age 45 by sharing real stories about young women whose lives have been affected by breast cancer.
Identifying Tools to Improve Clinical Preventive Services for Women with Disabilities
CDC and the Association of Maternal and Child Health Programs developed a toolbox for health professionals to facilitate and deliver clinical preventive services among the more than 28 million women of childbearing age and beyond living with disabilities.
Skin Cancer Prevention Progress Report 2015
Read about success stories from the field, and outcome indicators including Healthy People 2020, disease and behavioral surveillance, policy, and programs.
Protect Your Baby from Group B Strep!
Protect your baby from group B strep. If you're 35-37 weeks pregnant, talk with your doctor or midwife about getting a group B strep test.
Worldwide Hepatitis
Worldwide, approximately 240 million people have chronic Hepatitis B. Learn how the Hepatitis B vaccine is making a difference in preventing perinatal Hepatitis B transmission and saving millions of lives.
Sexual Activity, Contraceptive Use, and Childbearing of Teenagers Aged 15–19 in the United States
In 2011–2013, 44% of female teenagers and 47% of male teenagers aged 15–19 had experienced sexual intercourse; the percentage has declined significantly, by 14% for female and 22% for male teenagers, over the past 25 years.
Fetal and Perinatal Mortality: United States, 2013
This report presents 2013 fetal and perinatal mortality data by maternal age, marital status, race, Hispanic origin, and state of residence, as well as by fetal birthweight, gestational age, plurality, and sex. Trends in fetal and perinatal mortality are also examined.
Understanding Sex Trafficking
Sex trafficking exploits women, men, and children across the United States and around the world. Preventing this violation of health, safety, and human rights is necessary for the well-being of people and communities. Learn more about resources that prevention practitioners can use to help.
Sociodemographic and Psychological Characteristics of Very Light Smoking Among Women in Emerging Adulthood, National Survey of Drug Use and Health, 2011
Prevention programs targeting women in emerging adulthood need to recognize the prevalence of very light smoking in this population. From the Preventing Chronic Disease journal.
Receipt of Selected Clinical Preventive Services by Adults — United States, 2011–2012
During 2011–2012, those with insurance or with higher incomes were more likely than those without coverage or with lower incomes, respectively, to have received nine preventive services during the identified time period.
Pertussis and Influenza Vaccination Among Insured Pregnant Women — Wisconsin, 2013–2014
Prenatal care providers should implement, evaluate, and improve Tdap and influenza vaccination programs, and strongly recommend that pregnant patients receive these vaccines to prevent severe illness and complications among mothers and infants.
Differences in Stroke Mortality Among Adults Aged 45 and Over: United States, 2010–2013
The rate for non-Hispanic black women (131.4 per 100,000 population) was 30% higher than the rate for non-Hispanic white women, 58% higher than the rate for non-Hispanic Asian or Pacific Islander women, and 61% higher than the rate for Hispanic women of the same age.
Vital Signs: Demographic and Substance Use Trends Among Heroin Users — United States, 2002–2013
Heroin use and overdose deaths have increased significantly in the United States. The greatest increases in heroin use occurred in demographic groups that historically have had lower rates: doubling among women and more than doubling among non-Hispanic whites.  The rate in 2011–2013 for men was 3.6 per 1,000 compared with 1.6 per 1,000 for women.
Today’s Heroin Epidemic
Heroin use has increased across the US among men and women, most age groups, and all income levels. Some of the greatest increases occurred in demographic groups with historically low rates of heroin use: women, the privately insured, and people with higher incomes.
Help Children with Congenital CMV Live Healthy
Pregnant women can pass CMV to their unborn baby if they were infected before or during pregnancy. It is not known what factors lead to a woman with CMV giving birth to a baby with congenital CMV. CMV is passed from infected people to others through direct contact with body fluids such as blood, urine, saliva, blood, breast milk, or semen.
Cardiovascular Disease Prevention and Control: Interventions Engaging Community Health Workers
The Community Preventive Services Task Force recommends interventions that engage community health workers to prevent cardiovascular disease (CVD). There is strong evidence of effectiveness for interventions that engage community health workers in a team-based care model to improve blood pressure and cholesterol in patients at increased risk for CVD.
U.S. Census Populations with Bridged Race Categories
CDC’s National Center for Health Statistics used the unrevised July 1, 2010 bridged-race intercensal population estimates to calculate two birth measures in the 2010 birth reports (the birth rates for married and unmarried women).  Rates using the revised bridged-race intercensal population estimates are forthcoming.
Deaths: Leading Causes for 2011
This report presents final 2011 data on the 10 leading causes of death in the United States by age, sex, race, and Hispanic origin. Leading causes of infant, neonatal, and postneonatal death are also presented. Comparing 2011 with 2010, no changes occurred in the rank order of the 10 leading causes of death among females.
Deaths: Final Data for 2011
Life expectancy for the total population was 78.7 years in 2011, the same as in 2010. Life expectancy increased for the black and white populations. White males, black males, and black females experienced an increase in life expectancy in 2011 compared with 2010. The death rate for females increased for age groups 25–34 and 45–54.

CDC Funding

Snapshots

snapshot 1
Heroin Use Has Increased Among Most Demographic Groups
QuickStats: Annual Birth Rates, by Marital Status — National Vital Statistics System, United States, 1980–2014
QuickStats: Percentage of Currently Employed Adults Who Had Paid Sick Leave, by Industry — National Health Interview Survey, United States, 2009–2013
Figure 1. Age-Adjusted Stroke Death Rates among Men and Women Aged 45 and Over, by Race and Hispanic Origin: Average Annual, 2010–2013
Figure 4. Methods of Contraception Ever Used among Females Aged 15–19 Who Had Ever had Sexual Intercourse: United States
QuickStats: Death Rates* from Unintentional Injury Among Adults Aged ≥65 Years, by Cause of Death† and Sex — National Vital Statistics System

Features | USA.gov

Features | USA.gov



Social media has become a great way to communicate with friends. Unfortunately, scammers are taking advantage of this in order to steal your identity. Known as “farcing,” these scams start when you get a friend request from someone who supposedly shares mutual friends with you. And that's just the beginning.
Learn how to recognize and avoid this common social media scam and other online scams.

QuickStats: Death Rates* from Unintentional Injury Among Adults Aged ≥65 Years, by Cause of Death† and Sex — National Vital Statistics System, United States, 2012–2013

QuickStats: Death Rates* from Unintentional Injury Among Adults Aged ≥65 Years, by Cause of Death† and Sex — National Vital Statistics System, United States, 2012–2013



MMWR Logo
 
MMWR Weekly
Vol. 64, No. 29
July 31, 2015
 
PDF of this issue


QuickStats: Death Rates* from Unintentional Injury Among Adults Aged ≥65 Years, by Cause of Death and Sex — National Vital Statistics System, United States, 2012–2013

Weekly

July 31, 2015 / 64(29);807


The figure is a bar chart showing that during 2012-2013, among persons aged ≥65 years, men had higher age-adjusted death rates than women from all unintentional injuries, (128.3 versus 84.1 deaths per 100,000 population, respectively), and from the five leading causes of unintentional injury death. Death rates due to falls were the highest for both men and women, with the rates for men 1.4 times higher than the rates for women (66.7 versus 48.8). Compared to women, age-adjusted death rates for men were 2.1 times higher for motor vehicle traffic crashes (21.0 versus 9.9).
* Per 100,000 population, age-adjusted to the 2000 U.S. standard population.
Unintentional injury deaths are identified using the International Classification of Diseases, Tenth Revision (ICD-10) underlying cause of death codes V01-X59, Y85-Y86 (all unintentional); W00-W19 (fall); [V02–V04](.1,.9), V09.2, [V12–V14](.3–.9), V19(.4–.6), [V20–V28](.3–.9), [V29–V79](.4–.9), V80(.3–.5), V81.1, V82.1, [V83–V86](.0–.3), V87(.0–.8), V89.2 (motor vehicle traffic); W75-W84 (suffocation); X40-X49 (poisoning); and X00-X09 (fire or flame).
95% confidence interval.
During 2012–2013, among persons aged ≥65 years, men had higher age-adjusted death rates than women from all unintentional injuries, (128.3 versus 84.1 deaths per 100,000 population, respectively), and from the five leading causes of unintentional injury death. Death rates due to falls were the highest for both men and women, with the rates for men 1.4 times higher than the rates for women (66.7 versus 48.8). Compared to the age-adjusted death rates for women, the rates for men were 2.1 times higher for motor vehicle traffic crashes (21.0 versus 9.9).
Source: National Vital Statistics System mortality data. Available at http://www.cdc.gov/nchs/deaths.htm.
Reported by: Ellen A. Kramarow, PhD, ekramarow@cdc.gov, 301-458-4325; Yahtyng Sheu, PhD.
Alternate Text: The figure above is a bar chart showing that during 2012-2013, among persons aged ≥65 years, men had higher age-adjusted death rates than women from all unintentional injuries, (128.3 versus 84.1 deaths per 100,000 population, respectively), and from the five leading causes of unintentional injury death. Death rates due to falls were the highest for both men and women, with the rates for men 1.4 times higher than the rates for women (66.7 versus 48.8). Compared to women, age-adjusted death rates for men were 2.1 times higher for motor vehicle traffic crashes (21.0 versus 9.9).

Errata: Vol. 64, No. 28

Errata: Vol. 64, No. 28

MMWR Logo
 
MMWR Weekly
Vol. 64, No. 29
July 31, 2015
 
PDF of this issue


Errata: Vol. 64, No. 28

Weekly

July 31, 2015 / 64(29);806


In the report, "Launch of a Nationwide Hepatitis C Elimination Program — Georgia, April 2015," on page 755, the second sentence should read, "MoLHSA partnered with Gilead Sciences, a pharmaceutical manufacturer that agreed to support the program by providing an initial 5,000 courses of the antiviral medications sofosbuvir (Sovaldi), followed by 20,000 treatment courses of ledipasvir-sofosbuvir (Harvoni) annually at no cost.

Errata: Vol. 64, No. 22

Errata: Vol. 64, No. 22



MMWR Logo
 
MMWR Weekly
Vol. 64, No. 29
July 31, 2015
 
PDF of this issue


Errata: Vol. 64, No. 22

Weekly

July 31, 2015 / 64(29);806


In the report, "Use of Serogroup B Meningococcal Vaccines in Persons Aged ≥10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2015," on page 610, the fifth paragraph should read as follows: "In four clinical trials (9–11,13) a total of 2,557 subjects received at least 1 dose of MenB-FHbp (21); no serious adverse events considered by the study investigator to be related (or possibly related) to the vaccine were reported. In three additional studies (12) (Pfizer, unpublished data) with a total of 7,251 subjects receiving at least 1 dose of MenB-FHbp, four subjects reported seven serious adverse events that were considered by the study investigator to be related (or possibly related) to the vaccine.§ All vaccine-related serious adverse events resolved without sequelae. No increased risk for any specific serious adverse event considered to be clinically significant was identified in any of the studies. No deaths were considered to be related to MenB-FHbp. The most common solicited adverse reactions observed in the 7 days after receipt of MenB-FHbp in the clinical trials were pain at the injection site, fatigue, headache, myalgia, and chills (21)."

Errata: Vol. 64, No. 18

Errata: Vol. 64, No. 18

MMWR Logo
 
MMWR Weekly
Vol. 64, No. 29
July 31, 2015
 
PDF of this issue


Errata: Vol. 64, No. 18

Weekly

July 31, 2015 / 64(29);806


In the report, "Controlling the Last Known Cluster of Ebola Virus Disease — Liberia, January–February 2015, the author list should read as follows: Tolbert Nyenswah1, Mosoka Fallah1, Sonpon Sieh1, Karsor Kollie1, Moses Badio1, Alvin Gray1, Priscilla Dilah1, Marnijina Shannon1, Stanley Duwor1, Chikwe Ihekweazu2, Thierry Cordier-Lasalle2, Shivam A. Shinde2, Esther Hamblion2, Gloria Davies-Wayne2, Murugan Ratnesh2, Christopher Dye2, Jonathan S. Yoder3, Peter McElroy3, Brooke Hoots3, Athalia Christie3, John Vertefeuille3, Sonja J. Olsen3, A. Scott Laney3, Joyce J. Neal3Sirin Yaemsiri3, Thomas R. Navin3, Stewart Coulter3, Paran Pordell3, Terrence Lo3, Carl Kinkade3, Frank Mahoney3

Announcement: Additional Guidance Online for Providers Regarding 9-Valent HPV Vaccine Use Among Persons Who Previously Received HPV Vaccination

Announcement: Additional Guidance Online for Providers Regarding 9-Valent HPV Vaccine Use Among Persons Who Previously Received HPV Vaccination



MMWR Logo
 
MMWR Weekly
Vol. 64, No. 29
July 31, 2015
 
PDF of this issue




Announcement: Additional Guidance Online for Providers Regarding 9-Valent HPV Vaccine Use Among Persons Who Previously Received HPV Vaccination

Weekly

July 31, 2015 / 64(29);806


A 9-valent human papillomavirus (HPV) vaccine (Gardasil 9, Merck and Co., Inc.) was licensed for use in females and males in the United States in December 2014 (1,2). This is the third HPV vaccine licensed by the Food and Drug Administration; the other vaccines are the bivalent HPV vaccine, licensed for use in females, and the quadrivalent HPV vaccine, licensed for use in females and males (3).
In February 2015, the Advisory Committee on Immunization Practices (ACIP) recommended 9-valent HPV vaccine as one of three HPV vaccines that can be used for routine vaccination of females and one of two HPV vaccines for routine vaccination of males. ACIP recommendations were published in a March 2015 report (4). Additional information has been posted on the CDC website to provide guidance on issues that were not addressed in the March report but are likely to arise during the transition to 9-valent HPV vaccine, including questions about use of 9-valent HPV vaccine among persons who previously received bivalent or quadrivalent HPV vaccine (http://www.cdc.gov/vaccines/who/teens/downloads/9vHPV-guidance.pdf Adobe PDF file).

References

  1. Food and Drug Administration. Highlights of prescribing information: Gardasil 9 (human papillomavirus 9-valent vaccine, recombinant). Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2014. Available athttp://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM426457.pdf Adobe PDF fileExternal Web Site Icon.
  2. Joura EA, Giuliano AR, Iversen OE, et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med 2015;372:711–23.
  3. Markowitz LE, Dunne EF, Saraiya M, et al. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2014;63:1–30.
  4. Petrosky E, Bocchini JA, Hariri S, et al. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2015;64:300–4.